IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v3y2012i1d10.1038_ncomms1859.html
   My bibliography  Save this article

Metformin elicits anticancer effects through the sequential modulation of DICER and c-MYC

Author

Listed:
  • Giovanni Blandino

    (Translational Oncogenomics Unit, Italian National Cancer Institute)

  • Mariacristina Valerio

    (University of Rome 'La Sapienza')

  • Mario Cioce

    (Translational Oncogenomics Unit, Italian National Cancer Institute)

  • Federica Mori

    (Molecular Chemoprevention Unit, Italian National Cancer Institute)

  • Luca Casadei

    (University of Rome 'La Sapienza')

  • Claudio Pulito

    (Molecular Chemoprevention Unit, Italian National Cancer Institute)

  • Andrea Sacconi

    (Translational Oncogenomics Unit, Italian National Cancer Institute)

  • Francesca Biagioni

    (Translational Oncogenomics Unit, Italian National Cancer Institute)

  • Giancarlo Cortese

    (Regina Elena Cancer Institute)

  • Sergio Galanti

    (Translational Oncogenomics Unit, Italian National Cancer Institute)

  • Cesare Manetti

    (University of Rome 'La Sapienza')

  • Gennaro Citro

    (Regina Elena Cancer Institute)

  • Paola Muti

    (Juravinski Cancer Center-McMaster University Hamilton
    School of Public Health-Harvard University)

  • Sabrina Strano

    (Molecular Chemoprevention Unit, Italian National Cancer Institute
    Juravinski Cancer Center-McMaster University Hamilton)

Abstract

Diabetic patients treated with metformin have a reduced incidence of cancer and cancer-related mortality. Here we show that metformin affects engraftment and growth of breast cancer tumours in mice. This correlates with the induction of metabolic changes compatible with clear anticancer effects. We demonstrate that microRNA modulation underlies the anticancer metabolic actions of metformin. In fact, metformin induces DICER expression and its effects are severely impaired in DICER knocked down cells. Conversely, ectopic expression of DICER recapitulates the effects of metformin in vivo and in vitro. The microRNAs upregulated by metformin belong mainly to energy metabolism pathways. Among the messenger RNAs downregulated by metformin, we found c-MYC, IRS-2 and HIF1alpha. Downregulation of c-MYC requires AMP-activated protein kinase-signalling and mir33a upregulation by metformin. Ectopic expression of c-MYC attenuates the anticancer metabolic effects of metformin. We suggest that DICER modulation, mir33a upregulation and c-MYC targeting have an important role in the anticancer metabolic effects of metformin.

Suggested Citation

  • Giovanni Blandino & Mariacristina Valerio & Mario Cioce & Federica Mori & Luca Casadei & Claudio Pulito & Andrea Sacconi & Francesca Biagioni & Giancarlo Cortese & Sergio Galanti & Cesare Manetti & Ge, 2012. "Metformin elicits anticancer effects through the sequential modulation of DICER and c-MYC," Nature Communications, Nature, vol. 3(1), pages 1-11, January.
    • Handle: RePEc:nat:natcom:v:3:y:2012:i:1:d:10.1038_ncomms1859
    DOI: 10.1038/ncomms1859
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/ncomms1859
    File Function: Abstract
    Download Restriction: no
    File URL: https://libkey.io/10.1038/ncomms1859?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:3:y:2012:i:1:d:10.1038_ncomms1859. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.